The asymmetric synthesis of the antibacterial and antitumoral natural compound xylariolide A (1) and five stereoisomers has been achieved. The strategy is based on the onepot epoxidation/lactonisation or dihydroxylation/lactonisation of the hypothetical biosynthetic intermediate xylarioic
Introduction
Trisubstituted γ-butyrolactones are widely distributed in nature, and they display various biological activities. [1] Fungi from the Xylaria genus are an abundant source of natural products from different structural classes, including terpenoids, [2] cyclopeptides, [3] xanthones, [4] and polyketides. [5] The study of the metabolites produced by an endophytic fungal strain of Xylaria sp. NCY2, isolated from the medicinal plant Torreya jackii Chun, an evergreen shrub from the Taxaceae family, [6] led to the isolation of a polyketide γ-lactone named xylariolide A (1; Figure 1 ). Xylariolide A (1) is structurally related to the tetraketide acid moiety of 1-(xylarenone A) xylariate A (2), another metabolite isolated from the Xylaria sp. NCY2 strain. cus aureus, and shows moderate antitumoral activity against HepG2 and HeLa cells. [6] Spectroscopic analysis of isolated 1 led to the proposal that the relative stereochemistry of compound 1 was 3R*,4S*,5R*, on the basis of nOe correlations; no stereochemical assignments for carbons C-1Ј and C-2Ј were established in the original report.
As a part of an ongoing program of research into the chemical biology of fungal polyketides, including structural elucidation, biosynthetic, and synthetic studies, [7] our attention has been drawn to tetraketides such as xylariolide A (1) . The stereoselective preparation of compound 1 would allow the determination of its absolute stereochemistry, and would provide material for its biological evaluation. In this paper, we report the first stereoselective total synthesis of xylariolide A (1) and related stereoisomers (3R,4S,5R,1ЈS,2ЈR)-3 (1Ј-epi-xylariolide A), (3R,4S,5R,1ЈR,2ЈS)-4 (2Ј-epi-xylariolide A), (3R,4S,5R,1ЈS,2ЈS)-5, (3R,4S,5S,1ЈR,2ЈS)-6, and (3R,4S,5S,1ЈR,2ЈR)-7. We also report the stereoselective preparation of xylarioic acid A (8), i.e., the acid moiety of compound 2, and the assignment of the absolute stereochemistry of compound 1 as 3R,4S,5R,1ЈR,2ЈR.
Results and Discussion
The occurrence of xylarioic A acid (8) as a substructure of compound 2 suggests that 8 is a biosynthetic precursor of xylariolides A, B, and C. Based on this, we proposed a metabolite-inspired retrosynthetic analysis for a stereoselective synthesis of xylariolide A (1), as shown in Scheme 1. According to the data from the original report where the relative stereochemistry for the γ-lactone substituents was described, a total of eight possible stereoisomers of xylariolide A (1) have to be considered ( Figure 2 ). Therefore, a syn-thetic plan should consider the synthesis of diastereomers arising from all four possible configurations at the 1Ј and 2Ј positions. The stereochemistry at the other chiral centres should be either 3R,4S,5R or 3S,4R,5S, consistent with the assignment of the relative configuration of the natural product in which a cis relationship between the C-3 methyl, the C-5 methyl, and the C-4 hydroxy groups was determined by an nOe experiment. [6] Scheme 1. Retrosynthetic analysis for the synthesis of xylariolide A. Our strategy involved the stereoselective synthesis of intermediate 8 by the one-pot oxidation/olefination of 2-methylbutan-1-ol, followed by an anti asymmetric aldol reaction using an oxazolidinone chiral auxiliary. Starting from either racemic 2-methylbutan-1-ol or from (2S)-2-methylbutan-1-ol, the two epimers of (3R,4S,5R,1ЈR)-xylariolide at C-2Ј were obtained following the stereoselective synthetic route proposed in Scheme 2.
Enantiomerically pure acid (6S)-8 was prepared following the synthetic sequence showed in Scheme 2. Thus, (S)-2-methylbutan-1-ol was subjected to a one-pot oxidation/ olefination using N-methylmorpholine N-oxide (NMO; 1.0 equiv.) in the presence of tetrapropylammonium perruthenate (TPAP; 0.03 equiv.), in order to suppress the racemisation of the aldehyde intermediate, to produce (2E,4S)-ethyl 2,4-dimethylhex-2-enoate [(S)-10] in 67% yield. [8] Reduction of (S)-10 with DIBAL (diisobutylaluminum hydride) gave alcohol (S)-11, whose subsequent oxidation with PCC (pyridinium chlorochromate) produced the corresponding aldehyde [i.e., (S) -9] . [8] This aldehyde was treated with oxazolidin-2-one (+)-(S)-12 and catalytic amounts of MgCl 2 and NaSbF 6 [9] to give anti aldol product (6ЈЈS)-14 in 38 % yield and with 88 % dr.
[10] The configurations of C-2 and C-3 in the aldol product (i.e., 14) were confirmed by comparison of the NMR spectroscopic data and optical rotation of (6ЈЈS)-13, obtained by methanolysis of (6ЈЈS)-14, with those reported for the product of the aldol reaction between (S)-12 and 2-methylcinnamaldehyde, whose stereochemistry was unequivocally established by Evans et al. [9] Oxidative hydrolysis [11] of the chiral auxiliary in (6ЈЈS)-13 gave (2R,3S,4E,6S)-3-hydroxy-2,4,6-trimethyloct-4-enoic acid [(6S)-8], whose structure was confirmed by a combination of spectrometric and spectroscopic studies, with particular importance given to 1D and 2D NMR analysis. The constitution of compound (6S)-8 is the same as that of the side-chain of 1-(xylarenone A)xylariate A (2). The 1 H NMR spectroscopic data of (6S)-8 were very similar to those described for the xylarioyl A moiety of compound 2, [6] although some variations were observed in their 13 C NMR spectra, which could be due to stereochemical differences.
Acid (6S)-8 was subjected to a one-pot stereoselective epoxidation with m-CPBA (m-chloroperbenzoic acid), and a lactonisation catalysed by BF 3 ·Et 2 O [12] to give γ-butyrolactone 4. A series of nOe effects between the signals at δ H = 3.07, 4.58, and 3.64 ppm (due to H-3, H-4, and H-1Ј, respectively; Figure 3 ), consistent with a cis-cis relative configuration for the methyl and hydroxy groups in the lactone ring, supported the assignment of the stereochemistry of compound 4 as 3R,4S,5R,1ЈR,2ЈS. This outcome is consistent with the reaction mechanism outlined in Scheme 3 in which the hydroxy-directed epoxidation of (6S)-8 is predicted to give a threo-epoxide. [13] This then undergoes an epoxide ring opening by intramolecular nucleophilic attack of the carboxylic acid fragment with inversion of configuration at C-4, to give the lactone ring with a 3R,4S,5R,1ЈR configuration.
Comparison of the spectroscopic data of compound 4 with those reported for xylariolide A showed significant differences in both the 1 H and the 13 C NMR data, especially in those signals corresponding to the side-chain (see Tables 1 and 2 ). With the aim of examining whether these differences were due to the alternative stereochemistry at C- www.eurjoc.org1Ј, we prepared diastereoisomers of compound 4, with the same absolute stereochemistry at C-3, C-4, and C-5. Dihydroxylation of acid (6S)-8 catalysed by OsO 4 [14] gave a 1:1 mixture of the two triols resulting from syn-dihydroxylation on each of the faces of the olefin, and this was followed by in situ lactonisation to give lactones 5 and 6 (Scheme 4). NOe correlations between protons H-3, H-4, and H-1Ј in compound 5 were consistent with the relative configuration of the γ-butyrolactone moiety present in xylariolide A (1), but its observed physical and spectroscopic data turned out to be different from those reported for the natural product (see Tables 1 and 2 ). At this point, it seemed clear that natural xylariolide A or its enantiomer should have an alternative 2ЈR configuration. Therefore, our aim was to obtain the diastereomer of compound 4 that was epimeric at this position, which could be prepared stereoselectively following an identical synthetic sequence, starting from (R)-2-methylbutan-1-ol. [15, 16] Commercially available (Ϯ)-2-methylbutan-1-ol was subjected to one-pot oxidation/olefination using the TEMPO-BAIB [2,2,6,6-tetramethylpiperidin-1-oxyl and bis(acetoxy)-iodobenzene] system and (carbethoxyethylidene)triphenylphosphorane [17] to give (Ϯ)-(E)-ethyl 2,4-dimethylhex-2-enoate [(Ϯ)-10] in 61 % yield. [18] Reduction of (Ϯ)-10 with DIBAL and subsequent oxidation with PCC produced the corresponding aldehyde [i.e., (Ϯ) -9] . [8] This aldehyde was treated with oxazolidin-2-one [(+)-12] and catalytic amounts of MgCl 2 and NaSbF 6 [9] to give a 1:1 mixture of anti aldols (6ЈЈR)-13 and (6ЈЈS)-13 after methanolysis of the silyloxy derivatives (6ЈЈR)-14 and (6ЈЈS)-14 (Scheme 5). The mixture of (6ЈЈR)-13 and (6ЈЈS)-13 was subjected to oxidative hydrolysis [11] to give a 1:1 mixture of (2R,3S,4E,6R)-and (2R,3S,4E,6S)-3-hydroxy-2,4,6-trimethyloct-4-enoic acids, i.e., (6R)-8 and (6S)-8.
The 1:1 mixture of (6S)-8 and (6R)-8 was subjected to a one-pot stereoselective epoxidation with m-CPBA, and subsequent lactonisation catalysed by BF 3 ·Et 2 O [12] to give a 1:1 mixture of compounds 1 and 4, which were then separated by chromatographic methods. NOe's observed between the signals at δ H = 3.01, 4.55, and 3.45 ppm (H-3, H-4, and H-1Ј, respectively) supported the assignment of the stereochemistry for compound 1 as 3R,4S,5R,1ЈR,2ЈR.
The 13 C NMR chemical shifts of lactone 1 were identical to those reported for xylariolide A (Table 1) . However, there were slight differences in the signals corresponding to H-2Ј and H-3Ј in the 1 H NMR spectra (Table 2) . With the aim of ruling out the possibility that these differences were due to an alternative stereochemistry at C-1Ј, acids (6S)-8 and (6R)-8 were subjected to dihydroxylation catalysed by OsO 4 [14] to give a 1:1:1:1 mixture of four triols resulting from syn-dihydroxylation on both faces of the olefin on each diastereomer, which, after in situ lactonisation, led to the corresponding lactones (i.e., 3 and 5-7; Scheme 6). Lactone 3 showed nOe's consistent with those described for xylariolide A, but again its physical and spectroscopic data turned out to be different from those reported for the natural product (see Tables 1 and 2 ). All this data indicated that natural xylariolide A had a relative stereochemistry identical to that of compound 1, and that the slight differences observed between their 1 H NMR spectra could be due to errors in the definition of the intervals in the original report. 
Conclusions
We have synthesised four possible diastereoisomers of 4-hydroxy-5-(1-hydroxy-2-methylbutyl)-3,5-dimethyl-4,5-dihydrofuran-2(3H)-one in which the configuration of the lactone ring was consistent with the stereochemical description made in the original report by Hu et al. for xylariolide A. [6] Only compound 1 showed spectroscopic and physical data consistent with those reported for the natural compound. The slight differences in the 1 H NMR data between the isolated and synthetic material could be due to errors in the definition of the intervals in the original report (see Tables 1 and 2 ). Compound 1 was synthesised stereoselectively from (R)-2-methylbutan-1-ol, whose preparation has been reported previously in the literature. [16] Experimental Section General Methods: Unless otherwise noted, materials and reagents were obtained from commercial suppliers, and were used without further purification. Dichloromethane, ethyl acetate and triethylamine were freshly distilled from CaH 2 . Air-and moisture-sensitive reactions were performed under an argon atmosphere. Purification by semi-preparative and analytical HPLC was performed with a Hitachi/Merck L-6270 apparatus equipped with a differential refractometer detector (RI-7490). A LiChrospher ® Si 60 (5 μm) LiChroCart ® (250 mm ϫ 4 mm) column and a LiChrospher ® Si 60 (10 μm) LiChroCart ® (250 mm ϫ 10 mm) were used in isolation experiments. Silica gel (Merck) was used for column chromatography. TLC was performed on Merck Kiesegel 60 F 254 , 0.25 mm thick plates. Melting points were measured with a Reichert-Jung Kofler block. Optical rotations were determined with a digital polarimeter. Infrared spectra were recorded with a FTIR spectrophotometer and are reported in wavenumbers (cm -1 ). 1 H and 13 C NMR measurements were recorded with Varian Unity 400 MHz, Agilent 500 MHz, and Varian Inova 600 MHz spectrometers with SiMe 4 as the internal reference. Chemical shifts were referenced to CDCl 3 (δ H = 7.25, δ C = 77.0). NMR assignments were made using a combination of 1D and 2D techniques. Multiplicities are described using the following abbreviations: s = singlet, d = doublet, t = triplet, q = quartet; quint = quintuplet; sext = sextuplet; m = multiplet, br = broad. High-resolution mass spectra (HRMS) were recorded with a double-focussing magnetic sector mass spectrometer in positive ion mode, or with a QTOF mass spectrometer in positive ion APCI mode.
(2E,4S)-Ethyl 2,4-Dimethylhex-2-enoate [(S)-10]:
A mixture of (S)-2-methylbutan-1-ol (600 mg, 6.82 mmol), 4-methylmorpholine Noxide (NMO; 865 mg, 7.16 mmol) and molecular sieves (4 Å beads; 1.4 g) in dry CH 2 Cl 2 (13.6 mL) was stirred for 15 min. TPAP (126 mg, 0.2 mmol) was added to the resulting mixture. After stirring for 6 h at room temperature, (ethoxycarbonylethylidene)triphenylphosphorane was added, and the solution was stirred for a further 12 h at 35°C (3.9 g, 10.2 mmol). The mixture was then warmed to room temperature, the solvent was removed under reduced pressure, and the residue was purified by silica gel column chromatography (petroleum ether/Et 2 O, 97:3) to give ester (S)-10 (776.6 mg, 67 %). The spectroscopic data for compound (S)-10 were identical to those described in the literature. [8] 
(؎)-(E)-Ethyl 2,4-Dimethylhex-2-enoate [(؎)-10]:
TEMPO (561 mg, 3.50 mmol) and [bis(acetoxyiodo)benzene] (BAIB; 12.4 g, 38.70 mmol) were added at 0°C to a solution of (S)-2-methylbutan-1-ol (1550 mg, 17.60 mmol) in dry CH 2 Cl 2 (38.7 mL), and the mixture was stirred for 6 h. Then, (ethoxycarbonylethylidene)triphenylphosphorane (16.3 g, 44.02 mmol) was added, and the solution was stirred for a further 12 h at 35°C. The mixture was warmed to room temperature, the solvent was removed under reduced pressure, and the residue was purified by silica gel column chromatography (petroleum ether/Et 2 O, 97:3) to give ester (Ϯ)-10 (1826.3 mg, 61 %). The spectroscopic data for compound (Ϯ)-10 were identical to those described in the literature. [18] (2E,4S)-2,4-Dimethylhex-2-en-1-ol [(S)-11]: Diisobutylaluminum hydride (DIBAL; 1.0 m in CH 2 Cl 2 ; 4.3 mL, 4.3 mmol) was slowly added to a solution of (2E,4S)-ethyl 2,4-dimethylhex-2-enoate [(S)-10] (726 mg, 4.27 mmol) in dry CH 2 Cl 2 (13.4 mL), and the mixture was cooled to -78°C. When TLC monitoring indicated that the reaction was complete, Rochelle's salt (saturated aq.; 25 mL) was added, and the mixture was warmed to room temperature while maintaining vigorous stirring. The aqueous phase was extracted with CH 2 Cl 2 (3 ϫ 40 mL), and the combined organic extracts were washed, dried with anhydrous sodium sulfate and filtered. Evaporation of the solvent gave a crude residue, which was purified by silica gel column chromatography (petroleum ether/EtOAc, 80:20) to give (2E,4S)-2,4-dimethylhex-2-en-1-ol [(S)-11] (400.2 mg, 73 %), whose spectroscopic data were identical to those described in the literature. [18] 5 mL), and the solution was added dropwise to a suspension of PCC (1.031 g, 4.71 mmol) and powdered molecular sieves (4 Å, 2.062 g) in CH 2 Cl 2 (15 mL) at 0°C. The reaction mixture was stirred vigorously at 0°C for 2 h, then diethyl ether (50 mL) was added, and the mixture was stirred for an additional 1 h. The suspension was filtered through a silica gel pad (pentane/Et 2 O, 80:20, 300 mL). The solvent was concentrated under reduced pressure at 0°C to give aldehyde (S)-9 (364.0 mg, 92 %), which was used immediately in the next step. The spectroscopic data for compound (S)-9 were identical to those described in the literature. 8 mL) at 0°C. The mixture was then warmed to room temperature and stirred for 2 h. Sodium sulfite (1 m aq.; 1.12 mL, 1.12 mmol) was then added, and the mixture was stirred for an additional 20 min. The organic solvent was removed under reduced pressure, and the aqueous phase was extracted with CH 2 Cl 2 (3 ϫ 4 mL). The aqueous phase was acidified with HCl (1 m) to pH = 2 and then extracted with ethyl acetate (3 ϫ 15 mL). The combined organic extracts were dried with anhydrous sodium sulfate and filtered, and the solvent was evaporated under reduced pressure to give acid (6S)-8 (52.4 mg, 94 %) as a colourless oil, which was used in the next step without further purification. 38 (s, 3 H), 1.28-1.19 (m, 1 H) Supporting Information (see footnote on the first page of this article): Copies of the 1 H and 13 C NMR spectra for all key intermediates and final products, and nOe spectra of 1 and 3-7.
